Cargando…
Theracurmin Modulates Cardiac Inflammation in Experimental Model of Trypanosoma cruzi Infection
Theracurmin is a nanoparticle formulation derived from curcumin, a bioactive compound known for its antioxidant and anti-inflammatory properties. Trypanosoma cruzi, the etiological agent of Chagas disease, triggers an intense inflammatory response in mammals and also causes severe tissue damage. To...
Autores principales: | Louise, Vitória, Machado, Bianca Alves Almeida, Pontes, Washington Martins, Menezes, Tatiana Prata, Dias, Fernanda Carolina Ribeiro, Ervilhas, Luiz Otávio Guimarães, Pinto, Kelerson Mauro de Castro, Talvani, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384540/ https://www.ncbi.nlm.nih.gov/pubmed/37505639 http://dx.doi.org/10.3390/tropicalmed8070343 |
Ejemplares similares
-
Protective effects of Theracurmin treatment during experimental infection of the Colombian strain of Trypanosoma cruzi at the testicular site
por: Pimenta, Breno Luiz, et al.
Publicado: (2023) -
New Insights Into Blue Light Phototherapy in Experimental Trypanosoma cruzi Infection
por: Ivanova, Natália, et al.
Publicado: (2021) -
Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023) -
Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi
por: Wallukat, Gerd, et al.
Publicado: (2022) -
Diet Rich in Lard Promotes a Metabolic Environment Favorable to Trypanosoma cruzi Growth
por: de Souza, Débora Maria Soares, et al.
Publicado: (2021)